The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom.The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom.Vaccination and Immunization, Coronavirus (2019-nCoV), Research, BioNTech SE, Centers for Disease Control and Prevention, Food and Drug Administration, Pfizer Inc, National Institutes of Health, ElderlyRead More
